Theravance Biopharma, Inc.·4

Mar 4, 6:11 PM ET

Sawaf Aziz 4

4 · Theravance Biopharma, Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Ordinary Shares

    2025-02-28+75,000374,138 total

Documents

1 file
  • 4
    form4-03042025_110322.xmlPrimary